Latest filing published 13 Feb 2026 for Cannara Biotech Inc., €434k.
Zohar Krivorot appears in our data through filings on Cannara Biotech Inc. shares, published by SEDI. In total, 10 filings cover trades dated from 31 December 2018 to 11 February 2026.
No open-market sale appears; the market trades are 4 purchases worth €28k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 option exercises.
The median purchase comes to €6,392. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 13 February 2026, reports a transaction of €434k in Cannara Biotech Inc. The clock since the last published purchase (22 February 2023) now reads 1,343 days. The median gap between a trade and its publication by SEDI is 7 days. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations